CD42a (Megakaryocytic Cell Marker)

image not found

NABL Cap Accredited 
The Orange Healthcare CD42a (Megakaryocytic Cell Marker) Test is a specialised diagnostic investigation used to detect CD42a, also known as glycoprotein IX (GPIX), a cell-surface protein expressed on platelets and megakaryocytes, the bone marrow cells responsible for platelet production. CD42a forms part of the platelet glycoprotein Ib-IX-V complex, which plays an important role in platelet adhesion and normal blood clotting. The Orange Healthcare CD42a (Megakaryocytic Cell Marker) Test helps identify megakaryocytic cell populations and supports the evaluation of acute megakaryoblastic leukaemia and certain platelet disorders. Abnormal CD42a expression may provide information about platelet abnormalities or megakaryocytic differentiation. Results should be interpreted alongside other immunophenotypic markers, blood counts, bone marrow findings, and clinical investigations.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,750.00 Rs. 4,875.00

23% OFF

Sample Type: Blood

Fasting Not Required


Booking Procedure:
  1. Select your preferred Orange Health test or package on BookMyTest and complete your booking with your details.
  2. Pick a convenient time slot. A trained eMedic will be assigned and can reach you within 60 minutes of booking or at your scheduled time.
  3. At your selected time, a trained eMedic will visit your doorstep for safe and hygienic sample collection using a painless single-prick method. Samples are securely stored and transported to certified labs for processing.
  4. Doctor-verified reports are shared via WhatsApp, email, and the Orange Health app. You can also access them anytime from your registered account.

Frequently Asked Questions (FAQ's):

1. What is the Orange Healthcare CD42a (Megakaryocytic Cell Marker) Test?
It is a specialised laboratory test used to detect CD42a protein expression on platelets and megakaryocytes, helping identify megakaryocytic cell populations and investigate certain blood disorders.

2. Why is the CD42a (Megakaryocytic Cell Marker) Test performed?
The test is performed to support the diagnosis and classification of acute megakaryoblastic leukaemia, identify megakaryocytic differentiation in abnormal cells, and investigate selected platelet disorders.

3. What does a positive CD42a result indicate?
A positive result indicates CD42a expression in the examined cells. This may support megakaryocytic differentiation when interpreted alongside other markers, such as CD41 and CD61. CD42a positivity alone does not confirm malignancy.

4. What does a negative CD42a result indicate?
A negative result indicates that CD42a expression was not detected in the examined cell population. Reduced or absent expression may occur in immature megakaryoblasts or certain inherited platelet disorders, including Bernard-Soulier syndrome. Further investigations may be necessary.

5. Is fasting required for the Orange Healthcare CD42a (Megakaryocytic Cell Marker) Test?
Fasting is generally not required. However, patients undergoing bone marrow aspiration, tissue biopsy, or another invasive procedure should follow the preparation instructions provided by their healthcare team.

6. What sample is required for the CD42a (Megakaryocytic Cell Marker) Test?
The required specimen depends on the clinical indication and testing method. Peripheral blood or bone marrow aspirate samples may be analysed using flow cytometry to assess CD42a expression. Suitable tissue or bone marrow biopsy specimens may also be examined using immunohistochemistry, depending on the laboratory protocol.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab